medigraphic.com
ISSN 0188-9796 (Impreso)

2005, Número s1

<< Anterior Siguiente >>

Rev Endocrinol Nutr 2005; 13 (s1)


¿Podemos conseguir la meta de normoglucemia en la diabetes tipo 2?

Cooppan R

Idioma: Ingles.
Referencias bibliográficas: 10
Paginas: 22-25
Archivo PDF: 63.64 Kb.


FRAGMENTO

Sin resúmen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Standards of medical care in diabetes. Diabetes Care 2005; 28 Suppl 1: S4-36.

  2. Inzucchi S. Oral antihyperglycemic therapy for type 2 diabetes. JAMA 2002; 287: 360-372.

  3. Defronzo RA. Pharmacolgical therapy for type 2 diabetes mellitus. Annals Intern Med 1999; 131(40: 281-303.

  4. Nathan DM. Initial management of glycemia in type 2 diabetes mellitus. New Eng J Med 2002; 347: 1342-1349.

  5. Riddle MC, Scheinder. Beginning Insulin treatment of Obese Patients with Evening 70/30 Insulin Plus Glimepiride Versus Insulin alone. Diabetes Care 1998; 21(7): 1052-1057.

  6. Rosenstock J, Schwartz SL, Clark CM et al. Basal Insulin Therapy in Type 2 Diabetes. Diabetes Care 2001; 24(4): 631-636.

  7. Yki-Jarvinen H, Ryysy L, Nikkila K et al. Comparison of bedtime Insulin Regimens in Patients with Type 2 Diabetes Mellitus. Annals Intern Med 1999; 130(5): 389-396.

  8. Kendall DM, Riddle MC, Rosenstock J et al. Effects of Exenatide (Exendin-4) on Glycemic Control over 30 weeks in Patients With Type 2 Diabetes treated with Metformin and a Sulfonylurea. Diabetes Care 2005; 28: 1083-1091.

  9. Defronzo RA, Ratner RE, Han J et al. Effects of Exenatide (Exendin-4) on Glycemic control and Weight over 30 weeks in Metformin – Treated patients with Type 2 Diabetes. Diabetes Care 2005; 28: 1092-1100.

  10. Hollander PA, Levy P, Fineman MS et al. Pramlintide a s an adjunct to insulin therapy improves long term glycemic and weight control in patients with type 2 diabetes mellitus: a one year randomized controlled clinical trial. Diabetes Care 26: 784-790,2003




2020     |     www.medigraphic.com